Market Tracker

11/26 6:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.26
Data as of Nov 26
 +0.04 / +3.28%
Today’s Change
0.97
Today|||52-Week Range
2.25
-39.13%
Year-to-Date

Today’s Trading

Previous close1.22
Today’s open1.22
Day’s range1.22 - 1.26
Volume1,181,495
Average volume (3 months)864,887
Market cap$183.9M
Dividend yield--
Data as of 4:01pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+27.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...+0.21+2.84%
NNVCNanoViricides Inc+0.06+1.85%
EBIOEleven Biotherapeuti...+0.10+0.88%
THLDThreshold Pharmaceut...+0.04+1.38%
Data as of 4:01pm ET, 11/26/2014

Financials

Next reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Rick Gonzalez
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts